chr20-62260019-G-A
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The ENST00000313733.9(OSBPL2):c.76G>A(p.Ala26Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.002 in 1,613,896 control chromosomes in the GnomAD database, including 73 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Consequence
ENST00000313733.9 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
OSBPL2 | NM_144498.4 | c.76G>A | p.Ala26Thr | missense_variant | 3/14 | ENST00000313733.9 | NP_653081.1 | |
OSBPL2 | NM_014835.5 | c.40G>A | p.Ala14Thr | missense_variant, splice_region_variant | 3/14 | NP_055650.1 | ||
OSBPL2 | NM_001363878.2 | c.-291G>A | 5_prime_UTR_variant | 3/15 | NP_001350807.1 | |||
OSBPL2 | NM_001278649.3 | c.-184-3597G>A | intron_variant | NP_001265578.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
OSBPL2 | ENST00000313733.9 | c.76G>A | p.Ala26Thr | missense_variant | 3/14 | 1 | NM_144498.4 | ENSP00000316649 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0106 AC: 1619AN: 152130Hom.: 38 Cov.: 32
GnomAD3 exomes AF: 0.00268 AC: 675AN: 251410Hom.: 7 AF XY: 0.00204 AC XY: 277AN XY: 135892
GnomAD4 exome AF: 0.00110 AC: 1602AN: 1461648Hom.: 35 Cov.: 30 AF XY: 0.000968 AC XY: 704AN XY: 727142
GnomAD4 genome AF: 0.0107 AC: 1626AN: 152248Hom.: 38 Cov.: 32 AF XY: 0.0104 AC XY: 776AN XY: 74434
ClinVar
Submissions by phenotype
not provided Benign:3
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 18, 2024 | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | May 25, 2018 | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Aug 23, 2017 | p.Ala26Thr in exon 3 of OSBPL2: This variant is not expected to have clinical si gnificance because it has been identified in 3.52% (364/10354) of African chromo somes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org; dbSNP rs79783838). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at